Highlighted by the launch of UnityVue, a next-generation radiology reading solution, Mach7 will showcase Enterprise Imaging that connects clinicians and patients to enable exceptional care. SOUTH...

Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA...

HBI-3000 Aims to Fill Critical Gaps in Atrial Fibrillation Care; Key Data to be Presented at the American Heart Association Annual Meeting SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- HUYABIO...

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024, which includes a presentation...

-Flamingo is developing two RNA therapies for cancer: danvatirsen, an antisense oligonucleotide in Phase 2 PEMDA-HN study, and FLM-7523, a MALAT1 inhibitor approaching Phase 1- LEUVEN, Belgium and...